Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (15)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Pugh, P.J.
Right arrow Articles by Channer, K.S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pugh, P.J.
Right arrow Articles by Channer, K.S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Q J Med 2000; 93: 689-694
© 2000 Association of Physicians


Commentary papers

Testosterone: a natural tonic for the failing heart?

P.J. Pugh, K.M. English, T.H. Jones1 and K.S. Channer

From the Department of Cardiology, Royal Hallamshire Hospital 1 Department of Human Metabolism and Clinical Biochemistry, University of Sheffield, Sheffield, UK

Introduction

Chronic congestive heart failure (CHF) remains a significant cause of mortality and morbidity in the UK, accounting for 5% of acute hospital admissions and 1% of the total NHS budget.1 Coronary artery disease (CAD) and hypertension are the most commonly associated conditions. The condition is characterized by left ventricular dysfunction, impaired vascular tone and skeletal muscle abnormalities, producing breathlessness and fatigue. Neuro-hormonal and cytokine activation are self-perpetuating maladaptive responses to the failing heart, which cause further deterioration in cardiac function and increased catabolism.

The mainstay of current therapy includes diuretics and neuro-hormonal manipulation; ACE inhibitors are well established as the most important intervention for improving prognosis, and angiotensin II receptor antagonists offer a good alternative.2 More recently, reduced mortality has been demonstrated from the use of both beta-blockers and the aldosterone receptor antagonist spironolactone.3,4 Vasodilators may also . . . [Full Text of this Article]

Gonadal function in men with CHF

Effects on cardiovascular function

Skeletal muscle and strength

Neuro-hormonal activity

Cytokine activation

Conclusion

Notes

References


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Journals of Gerontology Series A: Biological Sciences and Medical SciencesHome page
J. E. Morley
Editorial: Andropause: Is It Time for the Geriatrician to Treat It?
J. Gerontol. A Biol. Sci. Med. Sci., May 1, 2001; 56(5): 263M - 265.
[Full Text]